glp-1 approved for pcos GLP-1s and PMOS: PCOS, Insulin Resistance, and Weight Loss Research Opportunity - GLP-1s and
Description
This also signals an important shift for women in midlife, especially those navigating menopause
Those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 shouldnt get GLP-1 drugs
There is a significant unmet need for improved therapies that can produce robust and sustained metabolic benefits for patients
2020;28:S486
13-25, 2026, among 2,117 U.S
GLP-1 receptor agonists routinely produce 1520% weight loss in clinical trials, rivaling results previously seen only with bariatric surgery
